Rajiv Kumar

QIMR Berghofer Medical Research Institute — Australia

Medicine · Health Sciences

35h-index4.4kcitations145works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Research on Leishmaniasis Studies(66), Trypanosoma species research and implications(39), Immune Cell Function and Interaction(21), Parasites and Host Interactions(13), Malaria Research and Control(8)

Publications145 total

Tali-cel is a safe and effective therapy in patients with Relapsed/Refractory B-cell non-Hodgkin lymphoma that allows equitable access- a real-world experience from India.
Blood·2025Open Access
Unveiling the molecular mechanisms of hemorrhagic shock and acute lung injury: An integrative RNA-Seq and network analysis
Translational research·2025
Amine-Functionalized Graphene Quantum Dots Conjugated with Amphotericin B: Synthesis, Characterization, and In Vitro Evaluation for Visceral Leishmaniasis Treatment
ACS Omega·2025· 3 citedOpen Access
Abstract P4-11-11: Real world data on breast cancer prognostication in India using CanAssist Breast- an indigenous test validated in global studies
Clinical Cancer Research·2025
The circulating plasma microRNA signature in human visceral leishmaniasis
mSphere·2025· 5 citedOpen Access
Advances and Challenges in the Diagnosis of Leishmaniasis
Molecular Diagnosis & Therapy·2025· 9 cited
P1307 Variant in Complement Factor B is associated with perianal disease in Ulcerative Colitis
Journal of Crohn s and Colitis·2025
Advancing Treatment for Leishmaniasis: From Overcoming Challenges to Embracing Therapeutic Innovations
ACS Infectious Diseases·2024· 10 cited
Anti-leishmanial therapies: overcoming current challenges with emerging therapies
Expert Review of Anti-infective Therapy·2024· 10 cited
Monitoring alpha-cypermethrin susceptibility of Phlebotomus argentipes, the vector of visceral leishmaniasis in India, using the CDC bottle bioassay
Parasites & Vectors·2024· 1 citedOpen Access
Dogs as Reservoirs for <i>Leishmania donovani</i>, Bihar, India, 2018–2022
Emerging infectious diseases·2024· 8 citedOpen Access
Chemokines Signature and T Cell Dynamics in Leishmaniasis: Molecular Insight and Therapeutic Application
Expert Reviews in Molecular Medicine·2024· 1 citedOpen Access
Influence of Proton Pump Inhibitor on clinical outcomes in Post Percutaneous Coronary Intervention Patients Receiving Clopidogrel-Meta Analysis
Journal of Ecophysiology and Occupational Health·2024Open Access
Navigating the Roadblocks: Progress and Challenges in Cell‐Based Therapies for Human Immunodeficiency Virus
Journal of Cellular Biochemistry·2024· 1 cited
Deciphering the landscape of triple negative breast cancer from microenvironment dynamics and molecular insights to biomarker analysis and therapeutic modalities
Medicinal Research Reviews·2024· 11 citedOpen Access
Investigational new drugs for the treatment of leishmaniasis
Expert Opinion on Investigational Drugs·2024· 4 cited
Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients
Clinical Lung Cancer·2024· 7 cited
Sustainable Synthesis of Novel Green-Based Nanoparticles for Therapeutic Interventions and Environmental Remediation
ACS Synthetic Biology·2024· 38 cited
Evaluation of blood based quantitative PCR as a molecular diagnostic tool for post kala-azar dermal leishmaniasis (PKDL)
Molecular Biology Reports·2024· 2 cited
Apolipoprotein E Is Upregulated in Blood and Circulating Monocytes of Indian Patients With Visceral Leishmaniasis
Parasite Immunology·2024Open Access
page 1 of 8Next →

Frequent Co-authors

Shyam Sundar(20), Christian Engwerda(17), Susanna S. Ng(13), Susanne Nylén(9), Fabian de Labastida Rivera(9), Marcela Montes de(9), Patrick T. Bunn(9), Fiona H. Amante(9), Chelsea L. Edwards(9), Shashi Bhushan Chauhan(8), Om Prakash Singh(8), Kamlesh Gidwani(8), Vibhav Gautam(8), Ashraful Haque(7), David L. Sacks(7), Meru Sheel(7), Rebecca J. Faleiro(7), Marleen Boelaert(7), Teija Frame(6), Geoffrey R. Hill(6)